{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:10:29Z","timestamp":1787616629222,"version":"build-2736575974"},"reference-count":86,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 CA129975 (HSZ)"],"award-info":[{"award-number":["R01 CA129975 (HSZ)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kentucky Lung Cancer Research Program","award":["GB150463 (HSZ)"],"award-info":[{"award-number":["GB150463 (HSZ)"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Adenoviruses (Ads) have been extensively manipulated for the development of cancer selective replication, leading to cancer cell death or oncolysis. Clinical studies using E1-modified oncolytic Ads have shown that this therapeutic platform was safe, but with limited efficacy, indicating the necessity of targeting other viral genes for manipulation. To improve the therapeutic efficacy of oncolytic Ads, we treated the entire Ad genome repeatedly with UV-light and have isolated AdUV which efficiently lyses cancer cells as reported previously (Wechman, S. L. et al. Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection. Viruses 2016, 8, 6). In this report, we show that no mutations were observed in the early genes (E1 or E4) of AdUV while several mutations were observed within the Ad late genes which have structural or viral DNA packaging functions. This study also reported the increased release of AdUV from cancer cells. In this study, we found that AdUV inhibits tumor growth following intratumoral injection. These results indicate the potentially significant role of the viral late genes, in particular the DNA packaging genes, to enhance Ad oncolysis.<\/jats:p>","DOI":"10.3390\/v8120333","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T04:09:09Z","timestamp":1482466149000},"page":"333","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adenovirus with DNA Packaging Gene Mutations Increased Virus Release"],"prefix":"10.3390","volume":"8","author":[{"given":"Stephen","family":"Wechman","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Mei","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"McMasters","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY 40202, USA"},{"name":"Department of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY 40202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.gt.3301398","article-title":"Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial","volume":"8","author":"Mulvihill","year":"2001","journal-title":"Gene Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.1038\/sj.onc.1209048","article-title":"Development of transcriptionally regulated oncolytic adenoviruses","volume":"24","author":"Ko","year":"2005","journal-title":"Oncogene"},{"key":"ref_3","unstructured":"Knipe, D.M., and Howley, P.M. (2007). Fields Virology, Lippincott Williams & Wilkins."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3748\/wjg.v10.i24.3634","article-title":"Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial","volume":"10","author":"Lu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/mt.2014.53","article-title":"Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma","volume":"22","author":"Ye","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nurt.2009.04.011","article-title":"Oncolytic viral therapy of malignant glioma","volume":"6","author":"Parker","year":"2009","journal-title":"Neurotherapeutics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00109-007-0291-1","article-title":"Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer","volume":"86","author":"Nettelbeck","year":"2008","journal-title":"J. Mol. Med."},{"key":"ref_8","first-page":"3073","article-title":"Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo","volume":"63","author":"Zhao","year":"2003","journal-title":"Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Cheng, P.H., Rao, X.M., Wechman, S.L., Li, X.F., McMasters, K.M., and Zhou, H.S. (2015). Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1731-x"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1089\/hum.2010.227","article-title":"Strategies to enhance viral penetration of solid tumors","volume":"22","author":"Smith","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.gt.3302436","article-title":"Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas","volume":"12","author":"Galanis","year":"2005","journal-title":"Gene Ther."},{"key":"ref_13","first-page":"189","article-title":"Advantages and disadvantages of multiple different methods of adenoviral vector construction","volume":"45","author":"Seth","year":"2000","journal-title":"Methods Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"d1369","DOI":"10.2741\/A847","article-title":"Adenovirus and cell cycle control","volume":"7","author":"Kleinberger","year":"2002","journal-title":"Front. Biosci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0042-6822(87)90441-7","article-title":"Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection","volume":"156","author":"Barker","year":"1987","journal-title":"Virology"},{"key":"ref_16","first-page":"389","article-title":"Functions of the adenovirus E1B tumour antigens","volume":"5","author":"Stillman","year":"1986","journal-title":"Cancer Surv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.7.4.535","article-title":"Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis","volume":"7","author":"Lowe","year":"1993","journal-title":"Genes Dev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/sj.cgt.7700923","article-title":"Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells","volume":"13","author":"Zheng","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.virol.2006.02.009","article-title":"Gene expression profiles of normal human lung cells affected by adenoviral E1B","volume":"350","author":"Rao","year":"2006","journal-title":"Virology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/JVI.01708-07","article-title":"Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication","volume":"82","author":"Zheng","year":"2008","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.3390\/v7112905","article-title":"Oncolytic Replication of E1b-Deleted Adenoviruses","volume":"7","author":"Cheng","year":"2015","journal-title":"Viruses"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cheng, P.H., Rao, X.M., McMasters, K.M., and Zhou, H.S. (2013). Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057340"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00109-014-1214-6","article-title":"Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter","volume":"93","author":"Cheng","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1101\/gad.7.4.546","article-title":"Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B","volume":"7","author":"Debbas","year":"1993","journal-title":"Genes Dev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1073\/pnas.89.16.7742","article-title":"The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins","volume":"89","author":"Rao","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","first-page":"2570","article-title":"The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha","volume":"12","author":"White","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/JVI.76.9.4547-4558.2002","article-title":"Bak and Bax function to limit adenovirus replication through apoptosis induction","volume":"76","author":"Cuconati","year":"2002","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.274.5286.373","article-title":"An adenovirus mutant that replicates selectively in p53-deficient human tumor cells","volume":"274","author":"Bischoff","year":"1996","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14712598.1.3.525","article-title":"Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of phase I and II trials","volume":"1","author":"Kirn","year":"2001","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301377","article-title":"Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: What have we learned?","volume":"8","author":"Kirn","year":"2001","journal-title":"Gene Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/156800907780058817","article-title":"Clinical trials with oncolytic adenovirus in China","volume":"7","author":"Yu","year":"2007","journal-title":"Curr. Cancer Drug Targets."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1158\/1078-0432.CCR-08-1161","article-title":"A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models","volume":"15","author":"Cafferata","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mt.2009.262","article-title":"A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors","volume":"18","author":"Nemunaitis","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_34","first-page":"7464","article-title":"A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy","volume":"61","author":"DeWeese","year":"2001","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/1743-422X-10-293","article-title":"Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells","volume":"10","author":"Cheng","year":"2013","journal-title":"Virol. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/35106065","article-title":"To cycle or not to cycle: a critical decision in cancer","volume":"1","author":"Malumbres","year":"2001","journal-title":"Nat. Rev. Cancer."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00109-014-1214-6","article-title":"Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter","volume":"93","author":"Cheng","year":"2015","journal-title":"J. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2009.266","article-title":"Current issues and future directions of oncolytic adenoviruses","volume":"18","author":"Yamamoto","year":"2010","journal-title":"Mol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.4161\/cbt.216","article-title":"Cancer-specific viruses and the development of ONYX-015","volume":"2","author":"McCormick","year":"2003","journal-title":"Cancer Biol Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Wechman, S.L., Rao, X.M., Cheng, P.H., Gomez-Gutierrez, J.G., McMasters, K.M., and Zhou, H.S. (2016). Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer Selection. Viruses, 8.","DOI":"10.3390\/v8060167"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0092-8674(79)90275-7","article-title":"Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells","volume":"17","author":"Jones","year":"1979","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/sj.cgt.7700739","article-title":"E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells","volume":"11","author":"Rao","year":"2004","journal-title":"Cancer Gene Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1073\/pnas.97.3.1002","article-title":"Optimization of the helper-dependent adenovirus system for production and potency in vivo","volume":"97","author":"Sandig","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1248\/bpb.19.1518","article-title":"A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet","volume":"19","author":"Ishiyama","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/j.1460-2075.1989.tb03616.x","article-title":"Infectious Circular DNA of Human Adenovirus Type-5 - Regeneration of Viral-DNA Termini from Molecules Lacking Terminal Sequences","volume":"8","author":"Graham","year":"1989","journal-title":"EMBO J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1128\/jvi.70.10.7030-7038.1996","article-title":"Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted","volume":"70","author":"Zhou","year":"1996","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"8802","DOI":"10.1073\/pnas.91.19.8802","article-title":"An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3","volume":"91","author":"Bett","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10446","DOI":"10.1128\/JVI.75.21.10446-10454.2001","article-title":"Role for the adenovirus IVa2 protein in packaging of viral DNA","volume":"75","author":"Zhang","year":"2001","journal-title":"J. Virol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.virol.2004.06.011","article-title":"Adenovirus IVa2 protein plays an important role in transcription from the major late promoter in vivo","volume":"327","author":"Young","year":"2004","journal-title":"Virology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/jvi.71.1.539-547.1997","article-title":"Domain organization of the adenovirus preterminal protein","volume":"71","author":"Webster","year":"1997","journal-title":"J. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/jvi.71.9.6381-6389.1997","article-title":"Role of preterminal protein processing in adenovirus replication","volume":"71","author":"Webster","year":"1997","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1073\/pnas.79.7.2221","article-title":"Function of adenovirus terminal protein in the initiation of DNA replication","volume":"79","author":"Tamanoi","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1128\/JVI.77.2.915-922.2003","article-title":"Adenovirus type 5 DNA binding protein stimulates binding of DNA polymerase to the replication origin","volume":"77","author":"Brenkman","year":"2003","journal-title":"J. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.1128\/JVI.72.10.7860-7870.1998","article-title":"Encapsidation of viral DNA requires the adenovirus L1 52\/55-kilodalton protein","volume":"72","author":"Gustin","year":"1998","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1128\/jvi.66.10.6133-6142.1992","article-title":"Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers","volume":"66","author":"Hasson","year":"1992","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.virol.2012.05.021","article-title":"Mapping of nuclear import signal and importin alpha3 binding regions of 52K protein of bovine adenovirus-3","volume":"432","author":"Paterson","year":"2012","journal-title":"Virology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-2836(86)90477-8","article-title":"Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo","volume":"188","author":"Chatterjee","year":"1986","journal-title":"J. Mol. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1128\/jvi.55.2.379-386.1985","article-title":"Interactions among the three adenovirus core proteins","volume":"55","author":"Chatterjee","year":"1985","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/0022-1317-79-7-1677","article-title":"Adenovirus core protein V interacts with p32--a protein which is associated with both the mitochondria and the nucleus","volume":"79","author":"Matthews","year":"1998","journal-title":"J. Gen. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Alva, V., Ammelburg, M., Soding, J., and Lupas, A.N. (2007). On the origin of the histone fold. BMC Struct. Biol., 7.","DOI":"10.1186\/1472-6807-7-17"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1128\/JVI.00935-14","article-title":"Isolation and characterization of the DNA and protein binding activities of adenovirus core protein V","volume":"88","author":"Vaughan","year":"2014","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbapap.2010.01.011","article-title":"PONDR-FIT: A meta-predictor of intrinsically disordered amino acids","volume":"1804","author":"Xue","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"36510","DOI":"10.1074\/jbc.M607601200","article-title":"L4\u201333K, an adenovirus-encoded alternative RNA splicing factor","volume":"281","author":"Tormanen","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1128\/JVI.00652-13","article-title":"The adenovirus L4\u201333K protein regulates both late gene expression patterns and viral DNA packaging","volume":"87","author":"Wu","year":"2013","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1128\/JVI.01584-06","article-title":"The adenovirus L4 33-kilodalton protein binds to intragenic sequences of the major late promoter required for late phase-specific stimulation of transcription","volume":"81","author":"Ali","year":"2007","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1128\/JVI.00467-11","article-title":"Adenovirus structural protein IIIa is involved in the serotype specificity of viral DNA packaging","volume":"85","author":"Ma","year":"2011","journal-title":"J. Virol."},{"key":"ref_68","unstructured":"Knipe, D.M., and Howley, P.M. (1996). Fields Virology, Lippincott-Raven."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virol.2013.08.033","article-title":"Post translational modifications in adenovirus type 2","volume":"447","author":"Artemenko","year":"2013","journal-title":"Virology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.3390\/v6114536","article-title":"Structure, function and dynamics in adenovirus maturation","volume":"6","author":"Mangel","year":"2014","journal-title":"Viruses"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1099\/vir.0.80877-0","article-title":"The adenovirus capsid: major progress in minor proteins","volume":"86","author":"Vellinga","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/JVI.76.1.127-135.2002","article-title":"Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response","volume":"76","author":"Lengagne","year":"2002","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Bruder, J.T., Semenova, E., Chen, P., Limbach, K., Patterson, N.B., Stefaniak, M.E., Konovalova, S., Thomas, C., Hamilton, M., and King, C.R. (2012). Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responses. PLoS ONE, 7.","DOI":"10.1371\/annotation\/c110beed-3cac-48db-9039-ba4498d5db50"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6780","DOI":"10.1039\/C6OB00980H","article-title":"Replacing a single atom accelerates the folding of a protein and increases its thermostability","volume":"14","author":"Arnold","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.1408462111","article-title":"Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection","volume":"111","author":"Reddy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1126\/science.1187292","article-title":"Crystal structure of human adenovirus at 3.5 A resolution","volume":"329","author":"Reddy","year":"2010","journal-title":"Science"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0168-9525(99)01950-2","article-title":"Gene therapy: designer promoters for tumour targeting","volume":"16","author":"Nettelbeck","year":"2000","journal-title":"Trends Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/JVI.77.4.2640-2650.2003","article-title":"Developing novel oncolytic adenoviruses through bioselection","volume":"77","author":"Yan","year":"2003","journal-title":"J. Virol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1128\/JCM.00282-09","article-title":"Genomic analyses of recombinant adenovirus type 11a in China","volume":"47","author":"Yang","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/1097-0142(195611\/12)9:6<1211::AID-CNCR2820090624>3.0.CO;2-7","article-title":"Studies on the use of viruses in the treatment of carcinoma of the cervix","volume":"9","author":"Huebner","year":"1956","journal-title":"Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1038\/onc.2014.452","article-title":"C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy","volume":"34","author":"Klein","year":"2015","journal-title":"Oncogene"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1593\/neo.04391","article-title":"Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas","volume":"7","author":"Jiang","year":"2005","journal-title":"Neoplasia"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.virol.2011.04.017","article-title":"Adenoviruses induce autophagy to promote virus replication and oncolysis","volume":"416","author":"Rao","year":"2011","journal-title":"Virology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1666","article-title":"Autophagy: dual roles in life and death?","volume":"6","author":"Baehrecke","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4161\/auto.5338","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/12\/333\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:28:55Z","timestamp":1760210935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/8\/12\/333"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":86,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12]]}},"alternative-id":["v8120333"],"URL":"https:\/\/doi.org\/10.3390\/v8120333","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints201612.0098.v1","asserted-by":"object"}]},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}